Why should pharma invest in digital products for those living with rare diseases?
pharmaphorum
NOVEMBER 23, 2022
This could considerably increase the quality of consultations by allowing patients to consider and communicate with their practitioners, not just about the recent weeks, but about the past months or years. Social media-style sites for rare diseases can connect patient communities globally. A work of passion.
111 
Let's personalize your content